Yet the rough plan was to have the addendum research completed around end of 2014 with analysis and then provision to FDA for approval for >age 18 by March 2015. Hope that isn't off the table any more. A PXS update on progress would be nice and get this trading in 1.0 cents ratehr than 0.1 cents.
- Forums
- ASX - By Stock
- no news is not good news for sp
Yet the rough plan was to have the addendum research completed...
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.3¢ |
Change
0.003(7.50%) |
Mkt cap ! $59.04M |
Open | High | Low | Value | Volume |
4.1¢ | 4.3¢ | 4.0¢ | $19.03K | 466.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 209054 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 306202 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 209054 | 0.042 |
3 | 687872 | 0.041 |
3 | 450000 | 0.040 |
1 | 750000 | 0.039 |
1 | 52631 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 306202 | 5 |
0.044 | 1038744 | 6 |
0.045 | 975250 | 4 |
0.046 | 1100000 | 2 |
0.047 | 20000 | 1 |
Last trade - 15.45pm 10/10/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online